Sex — a potential factor affecting immune checkpoint inhibitor therapy for cancers

Wang et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69d808cd66a29169b4bedca6 — DOI: https://doi.org/10.3389/fimmu.2022.1024112

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Human autoimmune diseases: a comprehensive update· 2015 · 1,140 citations
2. Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis· 2018 · 982 citations
3. Sex disparities in cancer· 2019 · 86 citations
4. PD-1, gender, and autoimmunity· 2010 · 100 citations
5. Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials· 2022 · 305 citations